Monday 20 October 2014

Hospital Pharmaceuticals Market Growth 2014 - 2020

Pharmaceutical drug sales are sold through various channels such as retail, mail orders, clinics and hospitals. Retail channel generate sales followed by mail orders, and collectively account for more than 50% of the pharmaceutical drugs sales. Hospital however account for a smaller share of about 8.6% of the total sales. This report exclusively studies the market for pharmaceutical drugs that are sold or delivered to patients in hospital settings.

Browse the full Hospital Pharmaceuticals Market Report at http://www.transparencymarketresearch.com/hospital-pharmaceuticals-market.html

Global hospital pharmaceutical drugs market is segmented according to major therapeutic areas, which include: cardiology, oncology, nephrology and urology, neurology, pain and infection. Market for these major therapeutic areas has been further assessed according to drug classes. Cardiology segment is further divided into diuretic drugs, calcium channel inhibitors, anti-cholinergic agents, anti-arrhythmic agents, anti-adrenergic agents, and others (ACE inhibitors, angiotensin receptor blockers, anticoagulants). Oncology segment is further segmented into immunomodulating agents, alkylating agents, anti-metabolites, hormonal agents, and miscellaneous drugs. Nephrology and urology segment is further divided into diuretic drugs, anti-hypertensive agents, phosphate binders, anti-cholinergic agents and 5-alpha-reductase inhibitors. Neurology segment is divided into anti-anxiety, anti-migraine, anti-depressant and anti-psychotic drugs. Market for pain management drugs has been divided into anti-convulsant drugs, anesthetics, nonsteroidal anti-inflammatory drugs (NSAID), opioids, and non-narcotic analgesic drugs. Similarly anti-infective drugs market has been segmented into anti-bacterial drugs, anti-viral drugs, anti-fungal drugs and anti-parasite drugs. The report also provides a detailed list of potential phase III candidates for each of the therapeutic areas.

The market has been further studied from the point of view of major diseases in these therapeutic areas. Thus the cardiology market has been studied considering coronary heart diseases, stroke, high blood pressure (hypertension), heart failure and other cardiovascular diseases. Oncology drugs market has been studied for lung cancer, breast cancer, colorectal cancer, prostate cancer, and others. Nephrology and urology drugs market is studied for acute kidney failure, chronic kidney diseases, glomerular diseases, diabetes and other diseases. Neurology market has been studied for epilepsy, Alzheimer’s disease, Parkinson’s disease, multiple sclerosis, stroke and other diseases.


Market for pain has been studied for neuropathic pain, fibromyalgia, osteoarthritis, rheumatoid arthritis, cancer pain and others. The infection market is studied for major infectious disease such as tuberculosis, pneumonia, hepatitis A, hepatitis B, Candida infections, fungal meningitis, shigellosis, amoebiasis and other infections. The report also provides insights for various branded and blockbuster drugs under various therapeutic drug class along with other details such as manufacturer, approval date and the patent expiry.


The Global Hospital Pharmaceuticals Market is segmented into the following categories:

Cardiology
Anti-Adrenergic Drugs
Calcium Channel Blockers
Diuretic Drugs
Anti-Arrhythmic Drugs
Others


Oncology
Alkylating Agents
Anti-Metabolites
Hormonal Agents
Immunomodulating Agents
Miscellaneous Drugs

Nephrology and Urology
Diuretic Agents
Anti-Hypertensive Agents
Phosphate Binders
Anticholinergic Drugs
5-Alpha Reductase Inhibitors

Neurology
Anti-Anxiety Agents
Detail2Anti-Migraine Drugs
Antidepressant Drugs
Anti-Psychotic Drugs

Pain
Anticonvulsant Drugs
Anesthetic Drugs
Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
Opioids
Non-Narcotics Analgesic Drugs

Infection
Antibacterial Drugs
Antiviral Drugs
Antifungal Drugs
Antiparasite Drugs

Global Hospital Pharmaceuticals Market, by Major Indications

Cardiology
Coronary Heart Diseases
Stroke
High Blood Pressure
Heart Failure
Others

Oncology
Lung Cancer
Breast Cancer
Colorectal Cancer
Prostate Cancer
Others

Nephrology and Urology
Acute Kidney Failure
Chronic Kidney Diseases
Glomerular Diseases
Diabetes
Others

Neurology
Epilepsy
Alzheimer;s Disease
Parkinson;s Disease
Multiple Sclerosis
Others

Pain
Neuropathic Pain
Fibromyalgia
Osteoarthritis
Rheumatoid Arthritis
Cancer Pain

Infection
Detail1Tuberculosis
Pneumonia
Hepatitis A
Hepatitis B
Candida Infection
Fungal Meningitis
Shigellosis
Amoebiasis
Other

Global Hospital Pharmaceuticals Market, by Geography
North America
Europe
Asia Pacific
Rest of the World (RoW)


About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR's experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather and analyze information

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact
Ms. Sheela AK
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453

Posted by at
Labels: , , ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)